Your session is about to expire
← Back to Search
Community Paramedic Intervention for Diabetes Management
N/A
Waitlist Available
Led By Rozalina G McCoy, MD, MS
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Experience of level 3 hypoglycemia
Type 1 or type 2 diabetes
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1 month, 4 months
Awards & highlights
Study Summary
This trial will study a new intervention delivered by community paramedics to improve diabetes self-management and reduce diabetes distress.
Who is the study for?
Adults over 18 living in specific counties of southeast Minnesota with Type 1 or Type 2 diabetes who have had a severe low blood sugar event and can give informed consent. They must not be in long-term care, terminally ill, lack English skills, enrolled in certain programs, under hospice care, or have cognitive issues preventing consent.Check my eligibility
What is being tested?
The trial is testing Diabetes-REM intervention by community paramedics to improve self-care for diabetes patients who've had serious hypoglycemia. It aims to prevent further episodes, reduce stress related to diabetes management and enhance life quality.See study design
What are the potential side effects?
Since the interventions involve education and support rather than medications, there are no direct side effects like those from drugs. However, participants may experience varying levels of stress or anxiety as they adjust their lifestyle and habits.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have had severe low blood sugar that needed help from another person.
Select...
I have diabetes.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 1 month, 4 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 month, 4 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Diabetes Self-Management
Secondary outcome measures
Diabetes distress
Glycemic control
Health-related Quality of life (EQ-5D)
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Community Paramedic (CP) program and Education MaterialsExperimental Treatment2 Interventions
Subjects will receive CP home visits and telephone calls for 1 month, along with printed diabetes education materials and a resource guide for contacting their diabetes care team in addition to usual care.
Group II: Usual Care and Education MaterialsActive Control1 Intervention
Subjects will receive printed diabetes education materials and a resource guide for contacting their diabetes care team in addition to usual care.
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,242 Previous Clinical Trials
3,773,334 Total Patients Enrolled
22 Trials studying Diabetes
6,713 Patients Enrolled for Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,377 Previous Clinical Trials
4,315,661 Total Patients Enrolled
106 Trials studying Diabetes
138,638 Patients Enrolled for Diabetes
Rozalina G McCoy, MD, MSPrincipal InvestigatorMayo Clinic
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are currently receiving hospice care.You live in Freeborn, Mower, Olmsted, Steele, or Wabasha county.I have had severe low blood sugar that needed help from another person.I am younger than 18 years old.I have been treated for severe low blood sugar.You have a serious or very advanced illness.I am 18 years old or older.You live in a nursing home or assisted living facility.I have diabetes.I am able to understand and give informed consent.
Research Study Groups:
This trial has the following groups:- Group 1: Community Paramedic (CP) program and Education Materials
- Group 2: Usual Care and Education Materials
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger